In vivo significance of kinetic constants of protein proteinase inhibitors.

We describe the in vivo significance of the kinetic parameters which characterize the interaction between proteinases and protein proteinase inhibitors. Knowledge of the second-order association rate constant kass and in vivo inhibitor concentration allows the calculation of the delay time of inhibition, i.e., the time required for complete inhibition of a proteinase in vivo. The influence of biological substrates on the delay time is also analyzed. The extent of substrate breakdown during the delay time of inhibition may be computed from the various constants describing the proteinase/substrate/inhibitor interactions and the biological concentrations of proteinase and inhibitor. The in vivo partition of a proteinase between two inhibitors may be calculated if the kinetic parameters are known. We define a stability time for enzyme-inhibitor complexes as a minimal time during which the complexes may be considered as stable. This time is related to kdiss the dissociation rate constant of the reversible enzyme-inhibitor complex or to k, the breakdown rate constant of the complex formed with temporary inhibitors. The overall stability of the complex depends upon the ratio between the inhibitor concentration and Ki, the equilibrium dissociation constant of the complex. If this ratio is higher than 1000, a reversible inhibitor behaves like an irreversible one in vivo whatever the enzyme concentration.

[1]  G. Salvesen,et al.  Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.

[2]  W. Greco,et al.  Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors. , 1979, The Journal of biological chemistry.

[3]  D. Atlas The active site of porcine elastase. , 1975, Journal of molecular biology.

[4]  P. Métais,et al.  On the inhibition of elastase by serum. Some distinguishing properties of α1-antitrypsin and α2-macroglobulin , 1975 .

[5]  C. Tsou,et al.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. , 1982, Biochemistry.

[6]  I. Kato,et al.  Protein inhibitors of proteinases. , 1980, Annual review of biochemistry.

[7]  P. Henderson,et al.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. , 1972, The Biochemical journal.

[8]  J. Bieth,et al.  A kinetic study of the inhibition of human and bovine trypsins and chymotrypsins by the inter-alpha-inhibitor from human plasma. , 1976, Biochimica et biophysica acta.

[9]  M. Lazdunski,et al.  The Mechanism of Activation of Trypsinogen , 1969 .

[10]  J. Zahnley,et al.  Determiniation of trypsin-inhibitor complex dissociation by use of the active site titrant, p-nitrophenyl p'-guanidinobenzoate. , 1970, Biochemistry.

[11]  K. Ohlsson,et al.  Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. , 1982, Biochimica et biophysica acta.

[12]  J. Travis,et al.  Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. , 1982, The Journal of biological chemistry.

[13]  M. Lazdunski,et al.  Trypsin-pancreatic trypsin inhibitor association. Dynamics of the interaction and role of disulfide bridges. , 1972, Biochemistry.

[14]  J. Engel,et al.  Kinetics of the interaction of bovine pancreatic trypsin inhibitor (Kunitz) with alpha-chymotrypsin. , 1974, Biochemistry.

[15]  M. Dixon The graphical determination of Km and Ki , 1972 .

[16]  J. Travis,et al.  Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. , 1980, The Journal of biological chemistry.